Citation 102171

GERHAUSER,C: LEE,SK: KOSMEDER,JW: MORIARTY,RM: HAMEL,E: MEHTA,RG: MOON,RC: PEZZUTO,JM:. (1997). REGULATION OF ORNITHINE DECARBOXYLASE INDUCTION BY DEGUELIN, A NATURAL PRODUCT CANCER CHEMOPREVENTIVE AGENT.. 57(16)

Citation Details

Title	REGULATION OF ORNITHINE DECARBOXYLASE INDUCTION BY DEGUELIN, A NATURAL PRODUCT CANCER CHEMOPREVENTIVE AGENT.
Authors	GERHAUSER,C: LEE,SK: KOSMEDER,JW: MORIARTY,RM: HAMEL,E: MEHTA,RG: MOON,RC: PEZZUTO,JM:
Year	1997
Volume	57
Issue	16

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEGUELIN	ACTIVE
2	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEGUELIN	ACTIVE
3	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEGUELIN	STRONG ACTIVITY
4	ATP SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEGUELIN	STRONG ACTIVITY
5	TUBULIN POLYMERIZATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEGUELIN	EQUIVOCAL
6	COMPLEMENT C-3 CONVERTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEGUELIN	STRONG ACTIVITY
7	ATP LEVELS DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	DEGUELIN	STRONG ACTIVITY
8	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ROTENONE	STRONG ACTIVITY
9	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ROTENONE	ACTIVE
10	ATP SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ROTENONE	STRONG ACTIVITY
11	TUBULIN POLYMERIZATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ROTENONE	ACTIVE
12	NADH DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ROTENONE	STRONG ACTIVITY
13	ATP LEVELS DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	ROTENONE	STRONG ACTIVITY
14	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ROLLINIASTATIN 2	STRONG ACTIVITY
15	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ROLLINIASTATIN 2	STRONG ACTIVITY
16	ATP SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ROLLINIASTATIN 2	STRONG ACTIVITY
17	ATP LEVELS DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	ROLLINIASTATIN 2	STRONG ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COLCHICINE	ACTIVE
2	ATP SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COLCHICINE	INACTIVE
3	TUBULIN POLYMERIZATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COLCHICINE	ACTIVE
4	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COLCHICINE	INACTIVE
5	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PODOPHYLLOTOXIN	STRONG ACTIVITY
6	ATP SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PODOPHYLLOTOXIN	INACTIVE
7	TUBULIN POLYMERIZATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PODOPHYLLOTOXIN	ACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PODOPHYLLOTOXIN	ACTIVE
9	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PODOPHYLLOTOXIN	ACTIVE
10	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PODOPHYLLOTOXIN	INACTIVE
11	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VINCALEUKOBLASTINE	STRONG ACTIVITY
12	ORNITHINE DECARBOXYLASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VINCALEUKOBLASTINE	INACTIVE
13	ATP SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VINCALEUKOBLASTINE	INACTIVE
14	TUBULIN POLYMERIZATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VINCALEUKOBLASTINE	ACTIVE

Show SPARQL Queries (1)